Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

27 Sep 2005 12:09

Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2005 Chairman's statementIn the six months ended 30 June 2005 the Company incurred a loss before andafter taxation of ‚£74,000 (2004: ‚£229,000).Because of the lack of cash in the Company, creditors have increased butcontinue to be supportive.The directors are continuing to keep overheads to a minimum, the expenses beingthose necessary to maintain the Company's listing on AIM.The board continues to seek an acquisition for the Company.Owing to a technicality, the Company no longer has any authority to issue anyof its share capital and will therefore be convening an extraordinary generalmeeting for this purpose.Nicolas GreenstoneChairman27 September 2005Azure Holdings plcProfit and Loss Accountfor the six months ended 30 June 2005 6 months 6 months Year ended ended 30 ended 30 31 December June 2004 2004 June 2005 (unaudited) (audited) (unaudited) ‚£'000 ‚£'000 ‚£'000 Turnover - - - Administrative expenses (74) (229) (345) Operating loss (74) (229) (345) Loss on ordinary activities before (74) (229) (345)taxation Tax on loss on ordinary activities - - - Loss on ordinary activities after (74) (229) (345)taxation Retained loss for the period (74) (229) (345) Loss per ordinary share (0.15p) (0.65p) (0.86p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains andlosses.Azure Holdings plcBalance Sheetas at 30 June 2005 30 June 2005 30 June 31 December 2004 2004 (unaudited) (unaudited) (audited) ‚£'000 ‚£'000 ‚£'000 Current assets Debtors 3 14 7 Cash at bank and in hand 1 10 14 4 24 21 Creditors: amounts falling due within one (147) (81) (90)year Net current liabilities (143) (57) (69) Total assets less current liabilities (143) (57) (69) Net liabilities (143) (57) (69) Capital and reserves Called up Share Capital 5,475 5,371 5,475 Share Premium 10,279 10,279 10,279 Profit and loss account (15,897) (15,707) (15,823) Equity shareholders deficit (143) (57) (69) Azure Holdings plcCash Flow Statementfor the six months ended 30 June 2005 6 months ended 6 months ended 30 June 2005 30 June 2004 (unaudited) (unaudited) ‚£'000 ‚£'000 Net cash outflow from operating (13) (214)activities Financing Issue of ordinary shares - 105 Decrease in cash (13) (109)Azure Holdings plcNotes to the Interim Results 1. The interim results are unaudited and do not constitute statutory accounts within the meaning of section 240 of the Companies Act 1985. The figures for the year ended 31 December 2004 have been extracted from the statutory accounts filed with the registrar of companies on which the auditors gave an unqualified report. 2. The interim results have been prepared using the accounting policies set out in the statutory accounts for the year ended 31 December 2004. 3. The comparative figures for the unaudited interim results for the period ended 30 June 2004 are stated as announced on 29 September 2004. 4. Loss per share The earnings per share for the six months ended 30 June 2005 has beencalculated on the basis of the loss after taxation for the period of ‚£74,000(2004: ‚£229,000 ) and the weighted average number of shares in issue during theperiod of 48,317,569 (2004: 35,417,565). 5. The directors do not propose to pay a dividend for the period. 6. Copies of the interim results are available from the Company's registered office, One Great Cumberland Place, London, W1H 7AL. ENDAZURE HOLDINGS PLC
Date   Source Headline
6th Jul 20217:00 amRNSPatent update
17th Jun 20214:40 pmRNSSecond Price Monitoring Extn
17th Jun 20214:35 pmRNSPrice Monitoring Extension
27th May 202112:48 pmRNSResult of AGM
27th May 20217:00 amRNSKTH222 Evaluation Agreement Concluded
30th Apr 202112:00 pmRNSPosting of Annual Report and Notice of AGM
27th Apr 20217:00 amRNSFinal Results
1st Mar 20217:00 amRNSTotal Voting Rights
25th Feb 20217:00 amRNSBlock listing Interim Review
18th Feb 20213:39 pmRNSDirector/PDMR Shareholding
15th Feb 20217:00 amRNSExtension of Collaboration Agreement
19th Jan 202111:36 amRNSDirector Disclosure
19th Jan 20217:00 amRNSPatent Status Update
30th Nov 202011:04 amRNSHolding(s) in Company
30th Nov 20207:46 amRNSVAL201 Clinical Trial Full Data Results
10th Nov 20207:00 amRNSAgreement with Kalos Therapeutics
2nd Nov 20207:00 amRNSTotal Voting Rights and Block Listing Update
16th Oct 202011:05 amRNSSecond Price Monitoring Extn
16th Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20204:00 pmRNSExercise of Warrant
1st Oct 20207:00 amRNSTotal Voting Rights and Block Listing Update
30th Sep 202010:34 amRNSHolding(s) in Company
29th Sep 20204:13 pmRNSHolding(s) in Company
29th Sep 20207:00 amRNSExercise of Warrant
28th Sep 20204:41 pmRNSSecond Price Monitoring Extn
28th Sep 20204:35 pmRNSPrice Monitoring Extension
28th Sep 20207:00 amRNSVAL201 Clinical Trial Update
25th Sep 20204:41 pmRNSSecond Price Monitoring Extn
25th Sep 20204:36 pmRNSPrice Monitoring Extension
25th Sep 202011:55 amRNSHolding(s) in Company
24th Sep 202011:05 amRNSSecond Price Monitoring Extn
24th Sep 202011:00 amRNSPrice Monitoring Extension
23rd Sep 202012:39 pmRNSHolding(s) in Company
23rd Sep 20207:06 amRNSSecond Price Monitoring Extn
23rd Sep 20207:04 amRNSPrice Monitoring Extension
23rd Sep 20207:00 amRNSShare Price Movement / Exercise of Warrant
22nd Sep 20204:40 pmRNSSecond Price Monitoring Extn
22nd Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Warrants and Warrant Update
9th Sep 20206:01 pmRNSHolding(s) in Company
8th Sep 20204:04 pmRNSHolding(s) in Company
7th Sep 20201:30 pmRNSExercise of Warrant
7th Sep 20207:00 amRNSHalf-year Report
3rd Sep 20204:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20204:35 pmRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSTotal Voting Rights
28th Aug 20207:00 amRNSExercise of Warrants
20th Aug 202012:45 pmRNSHolding(s) in Company
19th Aug 20207:00 amRNSBlock Listing Application and Company Update
18th Aug 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.